HIV/AIDS-Related Cancer: Latest Research

Approved by the Cancer.Net Editorial Board, 11/2018

ON THIS PAGE: You will read about the scientific research being done to learn more about HIV/AIDS-related cancers and how to treat them. Use the menu to see other pages.

Doctors are working to learn more about HIV/AIDS-related cancer, ways to prevent it, how to best treat it, and how to provide the best care to people diagnosed with these diseases. The following areas of research may include new options for patients through clinical trials. Always talk with your doctor about the best diagnostic and treatment options for you.

  • Combination therapies. Clinical trials are underway to study the effects of chemotherapy plus targeted therapy, and the role of ART given at the same time. The effect of high-dose therapy with bone marrow transplantation as well as chimeric antigen receptor T-cell (CAR-T) therapy are also being tested in clinical trials.

  • New therapies. There have been advances in the understanding of the biology of HIV/AIDS-related Kaposi sarcoma. New targeted therapies called kinase inhibitors block angiogenesis, which is the formation of new blood vessels that a tumor needs to grow and spread. In addition, a targeted therapy called imatinib (Gleevec) is being tested in clinical trials.

  • Palliative care/supportive care. Clinical trials are underway to find better ways of reducing symptoms and side effects of current cancer treatments to improve comfort and quality of life for patients.

Looking for More About the Latest Research?

If you would like additional information about the latest areas of research regarding Kaposi sarcoma, NHL, and cervical cancer, explore these related items that take you outside of this guide:

The next section in this guide is Coping with Treatment. It offers some guidance in how to cope with the physical, emotional, social, and financial changes that cancer and its treatment can bring. Use the menu to choose a different section to read in this guide.